167 related articles for article (PubMed ID: 34527218)
1. Pancreatic cancer incidence trends in the United States from 2000-2017: Analysis of Surveillance, Epidemiology and End Results (SEER) database.
Ali H; Pamarthy R; Vallabhaneni M; Sarfraz S; Ali H; Rafique H
F1000Res; 2021; 10():529. PubMed ID: 34527218
[No Abstract] [Full Text] [Related]
2. Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data.
Gordon-Dseagu VL; Devesa SS; Goggins M; Stolzenberg-Solomon R
Int J Epidemiol; 2018 Apr; 47(2):427-439. PubMed ID: 29149259
[TBL] [Abstract][Full Text] [Related]
3. Trends in the Incidence of Early-Onset Colorectal Adenocarcinoma Among Black and White US Residents Aged 40 to 49 Years, 2000-2017.
Montminy EM; Zhou M; Maniscalco L; Penrose H; Yen T; Patel SG; Wu XC; Karlitz JJ
JAMA Netw Open; 2021 Nov; 4(11):e2130433. PubMed ID: 34751760
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study.
Yadav S; Sharma P; Zakalik D
Am J Clin Oncol; 2018 May; 41(5):485-491. PubMed ID: 27322698
[TBL] [Abstract][Full Text] [Related]
5. Early estimates of cancer incidence for 2015: Expanding to include estimates for white and black races.
Lewis DR; Chen HS; Cockburn MG; Wu XC; Stroup AM; Midthune DN; Zou Z; Krapcho MF; Miller DG; Feuer EJ
Cancer; 2018 May; 124(10):2192-2204. PubMed ID: 29509274
[TBL] [Abstract][Full Text] [Related]
6. Thyroid cancer incidence patterns in Sao Paulo, Brazil, and the U.S. SEER program, 1997-2008.
Veiga LH; Neta G; Aschebrook-Kilfoy B; Ron E; Devesa SS
Thyroid; 2013 Jun; 23(6):748-57. PubMed ID: 23410185
[TBL] [Abstract][Full Text] [Related]
7. Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study.
Saad AM; Turk T; Al-Husseini MJ; Abdel-Rahman O
BMC Cancer; 2018 Jun; 18(1):688. PubMed ID: 29940910
[TBL] [Abstract][Full Text] [Related]
8. Contributions of Adenocarcinoma and Carcinoid Tumors to Early-Onset Colorectal Cancer Incidence Rates in the United States.
Montminy EM; Zhou M; Maniscalco L; Abualkhair W; Kim MK; Siegel RL; Wu XC; Itzkowitz SH; Karlitz JJ
Ann Intern Med; 2021 Feb; 174(2):157-166. PubMed ID: 33315473
[TBL] [Abstract][Full Text] [Related]
9. Incidence and trends of hepatic cancer among children and adolescents in the United States from 2000 to 2017: Evidence from the Surveillance, Epidemiology, and End Results registry data.
Li P; Kong Y; Guo J; Ji X; Han X; Zhang B
Cancer Causes Control; 2023 Jan; 34(1):69-79. PubMed ID: 36244051
[TBL] [Abstract][Full Text] [Related]
10. Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size.
Kuo EJ; Salem RR
Ann Surg Oncol; 2013 Sep; 20(9):2815-21. PubMed ID: 23771245
[TBL] [Abstract][Full Text] [Related]
11. Racial Disparities and Trends in Pancreatic Cancer Incidence and Mortality in the United States.
Tavakkoli A; Singal AG; Waljee AK; Elmunzer BJ; Pruitt SL; McKey T; Rubenstein JH; Scheiman JM; Murphy CC
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):171-178.e10. PubMed ID: 31202981
[TBL] [Abstract][Full Text] [Related]
12. Emerging incidence trends and application of curative treatments of pancreatic cancer in the USA.
Pei X; Song F; Wang Z
Medicine (Baltimore); 2019 Dec; 98(51):e17175. PubMed ID: 31860944
[TBL] [Abstract][Full Text] [Related]
13. Incidence Trends of Gastroenteropancreatic Neuroendocrine Tumors in the United States.
Lee MR; Harris C; Baeg KJ; Aronson A; Wisnivesky JP; Kim MK
Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2212-2217.e1. PubMed ID: 30580091
[TBL] [Abstract][Full Text] [Related]
14. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the incidence trend of follicular lymphoma from 2008 to 2017 in Taiwan and the United States using population-based data.
Su YC; Chiu BC; Li HJ; Yang WC; Chen TY; Yeh SP; Wang MC; Huang WT; Lee MY; Lin SF
PLoS One; 2022; 17(3):e0265543. PubMed ID: 35298555
[TBL] [Abstract][Full Text] [Related]
16. Non-functional pancreatic neuroendocrine tumours: emerging trends in incidence and mortality.
Wu J; Sun C; Li E; Wang J; He X; Yuan R; Yi C; Liao W; Wu L
BMC Cancer; 2019 Apr; 19(1):334. PubMed ID: 30961556
[TBL] [Abstract][Full Text] [Related]
17. Decreasing incidence of hepatocellular carcinoma among most racial groups: SEER-22, 2000-2019.
O'Brien TR; Devesa SS; Koshiol J; Marrero JA; Shiels MS
Cancer Med; 2023 Oct; 12(19):19960-19967. PubMed ID: 37776201
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival.
Halfdanarson TR; Rabe KG; Rubin J; Petersen GM
Ann Oncol; 2008 Oct; 19(10):1727-33. PubMed ID: 18515795
[TBL] [Abstract][Full Text] [Related]
19. US lung cancer trends by histologic type.
Lewis DR; Check DP; Caporaso NE; Travis WD; Devesa SS
Cancer; 2014 Sep; 120(18):2883-92. PubMed ID: 25113306
[TBL] [Abstract][Full Text] [Related]
20. Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004-2009.
Houston KA; Henley SJ; Li J; White MC; Richards TB
Lung Cancer; 2014 Oct; 86(1):22-8. PubMed ID: 25172266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
